Abstract
The intracellular pathogen, Mycobacterium tuberculosis (M. tb) uses various mechanisms to evade its killing. One of such is phagosomal damage and cytosolic translocation which is then targeted by the host’s bactericidal autophagy pathway. It is suggested that cytosolic translocation of M. tb is time-dependent, occurring at later time points of 48 to 72 h post-infection. It is, however, not known whether increased autophagic targeting correlates with these time points of infection. We investigated the time-dependent profile of autophagy activity through the course of M. tb infection in mammalian macrophages. Autophagy activity was inferred by the turnover measurement of autophagy markers and M. tb bacilli in THP-1 and RAW 264.7 macrophages. Over a period of 4 to 72 h, we observed highest autophagy turnover at 48 h of infection in M. tb-containing cells. This was evident by the highest turnover levels of p62 and intracellular M. tb. This supports observations of phagosomal damage mostly occurring at this time point and reveal the correlation of increased autophagy activity. The findings support the preservation of autophagy activity despite M. tb infection while also highlighting time-dependent differences in M. tb-infected macrophages. Future studies may explore time-dependent exogenous autophagy targeting towards host-directed anti-tuberculosis therapy.
Funder
National Research Foundation of South Africa
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference82 articles.
1. Robert Koch: Centenary of the discovery of the tubercle bacillus, 1882;Sakula;Thorax,1982
2. (2022, December 14). WHO Global Tuberculosis Report 2022. Available online: https://www.who.int/publications-detail-redirect/9789240061729.
3. Rekha, R.S., Mily, A., Sultana, T., Haq, A., Ahmed, S., Mostafa Kamal, S.M., van Schadewijk, A., Hiemstra, P.S., Gudmundsson, G.H., and Agerberth, B. (2018). Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy. BMC Infect. Dis., 18.
4. Therapeutic host-directed strategies to improve outcome in tuberculosis;Young;Mucosal Immunol.,2020
5. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: A review;Kiran;Semin. Immunopathol.,2016